Concepedia

Luis Lopez

LL

Statistics

Publications

7

Citations

180

H-Index

7

Active since

2011

Affiliations

Arena Pharmaceuticals (United States)(Current)

Luis Lopez is an author at Arena Pharmaceuticals (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2011–2014

7

Publications

7

Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor

Daniel J. Buzard, Sun Hee Kim, Luis Lopez et al. · ACS Medicinal Chemistry Letters · 2014 · 72 citations · Full text

, , +17

Complementary Asymmetric Routes to (<i>R</i>)-2-(7-Hydroxy-2,3-dihydro-1<i>H</i>-pyrrolo[1,2-<i>a</i>]indol-1-yl)acetate

Thomas O. Schrader, Benjamin Johnson, Luis Lopez et al. · Organic Letters · 2012 · 35 citations

, , +12

Fused tricyclic indoles as S1P1 agonists with robust efficacy in animal models of autoimmune disease

Daniel J. Buzard, Sangdon Han, Luis Lopez et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 18 citations · Full text

, , +11

Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptor

Daniel J. Buzard, Thomas O. Schrader, Xiuwen Zhu et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 18 citations · Full text

, , +12

(7-Benzyloxy-2,3-dihydro-<i>1H</i>-pyrrolo[1,2-<i>a</i>]indol-1-yl)acetic Acids as S1P<sub>1</sub> Functional Antagonists

Daniel J. Buzard, Luis Lopez, Jeanne Moody et al. · ACS Medicinal Chemistry Letters · 2014 · 16 citations · Full text

, , +15

1–5 of 7